title: The role of NF-kappa B1 (p50/p105) gene expression in activation of human blood T-lymphocytes via CD2 and CD28 adhesion molecules.
abstract: Stimulation of primary human T-lymphocytes via CD2 and CD28 adhesion molecules induces a long-lasting proliferation (> 3 weeks). This potent activation does not require accessory cells, such as monocytes, but depends on persistent interleukin 2 (IL-2) secretion and receptivity, which is associated with high and prolonged expression of the inducible CD25/IL-2 receptor alpha (IL-2R alpha) chain gene. The transcription factor NF-kappa B participates in the regulation of both IL-2 and IL-2R alpha genes, as well as multiple cellular genes involved in T-cell proliferation. To evaluate the role of NF-kappa B in human peripheral blood T-lymphocytes, we previously analyzed the activation of NF-kappa B-related complexes in response to CD2+CD28 costimulation. We demonstrated a long-term induction of p50/p65 heterodimer, a putative p65/c-Rel heterodimer, and a constitutive nuclear expression of KBF1/p50 homodimers. As the role of p50 remains unclear, we focused our present study on NF-kappa B1 (p50/p105) gene regulation. Using electrophoretic mobility shift assays and Western and Northern blot analyses, we studied NF-kappa B1 gene expression during T-cell stimulation via CD2+CD28. We observed a transient 4- to 5-fold increase of NF-kappa B1 gene expression at both the mRNA and protein levels, lasting for at least 24 h. p50 DNA-binding activity apparently stays highly controlled when p105 expression is enhanced by a physiological stimulus of peripheral blood T-cells. Partial inhibition of p50 and p105 expression by NF-kappa B1 antisense oligonucleotides significantly reduced T-cell proliferation and CD25/IL-2R alpha cell surface expression.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Unité 119, Institut National de la Santé et de la Recherche Médicale, Marseille, France.
authors.forename: R
authors.initials: R
authors.lastname: Costello
authors.forename: C
authors.initials: C
authors.lastname: Cerdan
authors.forename: C
authors.initials: C
authors.lastname: Lipcey
authors.forename: M
authors.initials: M
authors.lastname: Algarté
authors.forename: Y
authors.initials: Y
authors.lastname: Martin
authors.forename: P A
authors.initials: PA
authors.lastname: Baeuerle
authors.forename: D
authors.initials: D
authors.lastname: Olive
authors.forename: J
authors.initials: J
authors.lastname: Imbert
mesh_terms: D015703:Antigens, CD / Q000276:immunology*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology; D001483:Base Sequence; D001667:Binding, Competitive; D018801:CD2 Antigens; D018106:CD28 Antigens / Q000276:immunology; D015815:Cell Adhesion Molecules / Q000276:immunology; D004590:Electrophoresis, Paper; D004591:Electrophoresis, Polyacrylamide Gel / Q000379:methods; D005786:Gene Expression Regulation / Q000502:physiology*; D006801:Humans; D008213:Lymphocyte Activation / Q000276:immunology*; D008969:Molecular Sequence Data; D016328:NF-kappa B / Q000235:genetics*; D015345:Oligonucleotide Probes; D016376:Oligonucleotides, Antisense; D011506:Proteins / Q000032:analysis; D012333:RNA, Messenger / Q000032:analysis; D011971:Receptors, Immunologic / Q000276:immunology; D015375:Receptors, Interleukin-2 / Q000096:biosynthesis; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D015703:Antigens, CD; D000945:Antigens, Differentiation, T-Lymphocyte; D018801:CD2 Antigens; D018106:CD28 Antigens; D015815:Cell Adhesion Molecules; D016328:NF-kappa B; D015345:Oligonucleotide Probes; D016376:Oligonucleotides, Antisense; D011506:Proteins; D012333:RNA, Messenger; D011971:Receptors, Immunologic; D015375:Receptors, Interleukin-2